APA (7th ed.) Citation

Oh, J., Kang, C., Kim, S., Huh, K., Cho, S. Y., Chung, D. R., . . . Peck, K. R. (2020). Antifungal prophylaxis with posaconazole tablet and oral suspension in patients with haematologic malignancy: Therapeutic drug monitoring, efficacy and risk factors for the suboptimal level. Mycoses, 63(1), 89. https://doi.org/10.1111/myc.13020

Chicago Style (17th ed.) Citation

Oh, Jihyu, Cheol‐In Kang, Si‐Ho Kim, Kyungmin Huh, Sun Young Cho, Doo Ryeon Chung, Soo‐Youn Lee, Chul Won Jung, and Kyong Ran Peck. "Antifungal Prophylaxis with Posaconazole Tablet and Oral Suspension in Patients with Haematologic Malignancy: Therapeutic Drug Monitoring, Efficacy and Risk Factors for the Suboptimal Level." Mycoses 63, no. 1 (2020): 89. https://doi.org/10.1111/myc.13020.

MLA (9th ed.) Citation

Oh, Jihyu, et al. "Antifungal Prophylaxis with Posaconazole Tablet and Oral Suspension in Patients with Haematologic Malignancy: Therapeutic Drug Monitoring, Efficacy and Risk Factors for the Suboptimal Level." Mycoses, vol. 63, no. 1, 2020, p. 89, https://doi.org/10.1111/myc.13020.